BEMFOLA

This brand name is authorized in Australia, Austria, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Ireland, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug BEMFOLA contains one active pharmaceutical ingredient (API):

1	Follitropin alfa UNII VV3HN9ZPB5 - FOLLITROPIN ALFA
	In women, the most important effect resulting from parenteral administration of FSH is the development of mature Graafian follicles.
	Read more about Follitropin alfa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03GA05	Follitropin alfa	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10861P, 10865W, 10866X, 10867Y, 10872F, 10873G, 10876K, 10877L
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	219-MBE-1221, 224-MBE-0122, 225-MBE-0122, 226-MBE-0122, 227-MBE-0122
EE	Ravimiamet	1644892, 1644904, 1644915, 1644926, 1644937, 1683244, 1683255, 1683266, 1683277, 1683288, 1683299, 1683301, 1683312, 1683323, 1683334
ES	Centro de información online de medicamentos de la AEMPS	113909001, 113909002, 113909003, 113909004, 113909005, 113909007, 113909008, 113909009, 113909010, 113909011, 113909012, 113909013
FI	Lääkealan turvallisuus- ja kehittämiskeskus	083422, 189728, 374183, 422738, 429875, 489149, 515399, 582122
FR	Base de données publique des médicaments	62170657, 62854032, 64424905, 67933658, 68954979
GB	Medicines & Healthcare Products Regulatory Agency	297525, 297528, 297531, 297534, 297537
IE	Health Products Regulatory Authority	88433, 88434, 88436, 88437, 88438
LT	Valstybinė vaistų kontrolės tarnyba	1069567, 1073129, 1073159, 1073160, 1073161, 1075145, 1075146, 1075147, 1075148, 1075149, 1075150, 1075151, 1075152, 1075153, 1075154
NL	Z-Index G-Standaard, PRK	117552, 117560, 117579, 117587
NZ	Medicines and Medical Devices Safety Authority	18151, 18152, 18153, 18154, 18155
PL	Rejestru Produktów Leczniczych	100322746, 100322752, 100322769, 100322775, 100322781
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63833001, W63834001, W63835001, W63836001, W63837001